1. Home
  2. GOVX vs DCX Comparison

GOVX vs DCX Comparison

Compare GOVX & DCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$0.83

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Logo Digital Currency X Technology Inc. Class A Ordinary Shares

DCX

Digital Currency X Technology Inc. Class A Ordinary Shares

HOLD

Current Price

$0.97

Market Cap

4.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOVX
DCX
Founded
2001
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
4.5M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
GOVX
DCX
Price
$0.83
$0.97
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
196.2K
236.4K
Earning Date
04-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,489,145.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.34
52 Week High
$4.40
$5.68

Technical Indicators

Market Signals
Indicator
GOVX
DCX
Relative Strength Index (RSI) 43.96 43.96
Support Level $0.64 $0.94
Resistance Level $2.00 $1.32
Average True Range (ATR) 0.09 0.15
MACD 0.03 0.04
Stochastic Oscillator 56.54 43.66

Price Performance

Historical Comparison
GOVX
DCX

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

About DCX Digital Currency X Technology Inc. Class A Ordinary Shares

Digital Currency X Technology Inc, formerly Chijet Motor Company Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.

Share on Social Networks: